Amoxicillin/clavulanate potassium suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amoxicillin/clavulanate potassium suspension, covering 2009-08-25 to 2009-08-25. Get the full timeline:
Most recent: Clinical Trial Update: 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions [Phase 1]